keyword
https://read.qxmd.com/read/37385947/consensus-recommendations-for-the-screening-diagnosis-and-management-of-helicobacter-pylori-infection-in-hong-kong
#21
JOURNAL ARTICLE
W K Leung, K S Cheung, P C O Sham, R S Y Tang, C K Loo, A S J Hsu, T K Cheung, L Y Lam, B C F Chiu, J C Y Wu
Helicobacter pylori infection causes chronic gastric inflammation that contributes to various gastroduodenal diseases, including peptic ulcer and gastric cancer. Despite broad regional variations, the prevalence of resistance to antibiotics used to manage H pylori infection is increasing worldwide; this trend could hinder the success of eradication therapy. To increase awareness of H pylori and improve the diagnosis and treatment of its infection in Hong Kong, our consensus panel proposed a set of guidance statements for disease management...
June 30, 2023: Hong Kong Medical Journal
https://read.qxmd.com/read/37271531/-recent-topics-in-the-pathophysiology-and-treatment-of-immune-thrombocytopenic-purpura
#22
JOURNAL ARTICLE
Hirokazu Kashiwagi
Increased and impaired platelet productions via immunological abnormalities are the main pathophysiological mechanisms of primary immune thrombocytopenia (ITP). Recent studies have revealed that platelet removal from circulation involves not only Fc receptor-mediated phagocytosis of immunoglobulin G autoantibodies-bound platelets but also complement-dependent mechanism and platelet glycoprotein desialylation. Understanding the molecular mechanism of ITP pathophysiology has helped develop many novel molecular targeted drugs, and recent clinical trials have shown their effectiveness...
2023: [Rinshō Ketsueki] the Japanese Journal of Clinical Hematology
https://read.qxmd.com/read/37241315/effect-of-iron-tailing-powder-based-ternary-admixture-on-acid-corrosion-resistance-of-concrete
#23
JOURNAL ARTICLE
Bing Zhang, Yannian Zhang, Wenliang Liu, Xiaowei Gu, Qingjie Wang, Shaowu Zhang, Jian Gao
Exposure of concrete to acidic environments can cause the degradation of concrete elements and seriously affect the durability of concrete. As solid wastes are produced during industrial activity, ITP (iron tailing powder), FA (fly ash), and LS (lithium slag) can be used as admixtures to produce concrete and improve its workability. This paper focuses on the preparation of concrete using a ternary mineral admixture system consisting of ITP, FA, and LS to investigate the acid erosion resistance of concrete in acetic acid solution at different cement replacement rates and different water-binder ratios...
May 12, 2023: Materials
https://read.qxmd.com/read/37096545/-advances-in-the-treatment-of-glucocorticoid-resistance-and-relapsed-immune-thrombocytopenia-review
#24
JOURNAL ARTICLE
Hui-Min Pan, Rui-Ting Wen, Zhi-Gang Yang
Immune thrombocytopenia (ITP) is an immune-mediated acquired hemorrhagic autoimmune disease. At present, the first-line therapeutic drugs for ITP include glucocorticoids and intravenous immunoglobulins. However, about 1/3 of the patients had no response to the first-line treatment, or relapsed after dose reduction or withdrawal of glucocorticoids. In recent years, with the gradual deepening of the understanding on the pathogenesis of ITP, the drugs targeting different pathogenesis continually emerge, including immunomodulators, demethylating agents, spleen tyrosine kinase (SYK) inhibitors and neonatal Fc receptor (FcRn) antagonist...
April 2023: Zhongguo Shi Yan Xue Ye Xue za Zhi
https://read.qxmd.com/read/37065402/the-roles-and-challenges-of-advanced-therapies-in-the-management-of-refractory-immune-thrombocytopenia-a-case-report-and-review-of-the-literature
#25
Beatrice E Torere, Henry O Aiwuyo, Joseph Weigold, Gene Gerlach, Nosakhare Ilerhunmwuwa, Usman Khan, Tatiana Belousova
The management of primary immune thrombocytopenia (ITP) is becoming a subject of interest as there appears to be treatment failure and resistance to modern conventional treatment, necessitating a more universal and goal-directed approach to management. Our patient is a 74-year-old male who was diagnosed with ITP six years ago and recently presented to the emergency department (ED) with complaints of melena stools and severe fatigue lasting for two days. Prior to the ED presentation, he had received multiple lines of treatment including splenectomy...
March 2023: Curēus
https://read.qxmd.com/read/36660052/management-of-helicobacter-pylori-infection
#26
REVIEW
Natsuda Aumpan, Varocha Mahachai, Ratha-Korn Vilaichone
Helicobacter pylori infection exhibits a wide disease spectrum ranging from asymptomatic gastritis, peptic ulcer disease, to gastric cancer. H. pylori can induce dysbiosis of gastric microbiota in the pathway of carcinogenesis and successful eradication can restore gastric homeostasis. Diagnostic testing and treatment for H. pylori infection is recommended in patients with active or past history of peptic ulcer, chronic dyspepsia, chronic non-steroidal anti-inflammatory drugs (NSAID) or aspirin use, precancerous gastric lesions, gastric cancer, mucosa-associated lymphoid tissue (MALT) lymphoma, family history of gastric cancer, family history of peptic ulcers, household family member having active H...
January 2023: JGH Open: An Open Access Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/36546515/tacrolimus-prevents-complement-mediated-nod-like-receptor-family-pyrin-domain-containing-3-nlrp3-inflammasome-activation-and-pyroptosis-of-mesenchymal-stem-cells-from-immune-thrombocytopenia
#27
JOURNAL ARTICLE
Xuan Cai, Jin Wu, Zhuo-Yu An, Chen-Cong Wang, Xiao-Lu Zhu, Yun He, Hai-Xia Fu, Xiao-Jun Huang, Xiao-Hui Zhang
The abnormal immunomodulatory functions of mesenchymal stem cells (MSCs) have been implicated in the development of immune thrombocytopenia (ITP). Recent studies have suggested important effects of complement on immune cell function. However, whether complement modulates bone marrow MSCs function in ITP is poorly defined. Tacrolimus has recently been applied to the treatment of autoimmune diseases. Here, we explored whether impaired ITP-MSCs could be targeted by tacrolimus. Our results showed that the Nod-like receptor family pyrin domain containing 3 (NLRP3) inflammasome was activated in ITP MSCs with complement deposition (MSCs-C+ ) and initiated caspase-1-dependent pyroptosis...
September 2023: British Journal of Haematology
https://read.qxmd.com/read/36396570/plasma-cell-directed-therapy-for-immune-thrombotic-thrombocytopenic-purpura-ittp
#28
REVIEW
Melissa Chen, Jake Shortt
Immune thrombotic thrombocytopenic purpura (iTTP) is a microangiopathic hemolytic anemia (MAHA) underpinned by autoreactivity against the von Willebrand factor (vWF) cleaving protease, ADAMTS13 (adisintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13). Autoantibody mediated ADAMTS13 inhibition leads to the accumulation of ultra-large vWF multimers which activate platelets and endothelium to initiate microvascular thrombosis. In the absence of urgent therapeutic intervention, iTTP is rapidly fatal due to cumulative organ dysfunction including catastrophic neurological and cardiac sequalae...
October 2022: Transfusion Medicine Reviews
https://read.qxmd.com/read/36355549/danazol-in-refractory-autoimmune-hemolytic-anemia-or-immune-thrombocytopenia-a-case-series-report-and-literature-review
#29
JOURNAL ARTICLE
Hsu-En Huang, Ko-Ming Lin, Jing-Chi Lin, Yu-Ting Lin, Hsiao-Ru He, Yu-Wei Wang, Shan-Fu Yu, Jia-Feng Chen, Tien-Tsai Cheng
Danazol is a treatment option for autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Three patients with AIHA and eight patients with ITP between 2008 and 2022 were enrolled in the Rheumatology Outpatient Clinic of Chang Gung Memorial Hospital, Kaohsiung. Those patients were refractory or intolerant to conventional therapy and were treated with danazol. All the patients received an initial dose of danazol (200-400 mg). The observation period was 6 months. Three patients (100%) with AIHA and six (75%) with ITP achieved treatment response after 6 months of danazol therapy...
November 9, 2022: Pharmaceuticals
https://read.qxmd.com/read/36310591/the-ifng-antisense-rna-1-ifng-as1-and-growth-arrest-specific-transcript-5-gas5-are-novel-diagnostic-and-prognostic-markers-involved-in-childhood-itp
#30
JOURNAL ARTICLE
Marwa A Ali, Sherin Khamis Hussein, Abeer A Khalifa, Amani M El Amin Ali, Marwa S Farhan, Amal A Ibrahim Amin, Esam Ali Mohamed
Background/aim: IFNG-AS1 is a long noncoding RNA that works as an enhancer for the Interferon-gamma (IFN-γ) transcript. GAS5 (growth arrest-specific 5) is a lncRNA that is associated with glucocorticoid resistance. Aberrant expressions of IFNG-AS1 and GAS5 are directly linked to numerous autoimmune disorders but their levels in childhood ITP are still obscure. This study aims to elucidate expressions of target lncRNAs in childhood ITP and their association with pathophysiology and clinical features of the disease as well as their association with types and treatment responses...
2022: Frontiers in Molecular Biosciences
https://read.qxmd.com/read/36050760/impaired-mitochondria-of-tregs-decreases-oxphos-derived-atp-in-primary-immune-thrombocytopenia-with-positive-plasma-pathogens-detected-by-metagenomic-sequencing
#31
JOURNAL ARTICLE
Yanxia Zhan, Jingjing Cao, Lili Ji, Miaomiao Zhang, Qi Shen, Pengcheng Xu, Xibing Zhuang, Shanshan Qin, Fanli Hua, Lihua Sun, Feng Li, Hao Chen, Yunfeng Cheng
BACKGROUND: Primary immune thrombocytopenia (ITP) is an autoimmune disease. Some ITP patients are associated with pathogen infection undetected with conventional technologies. Investigating the changes of T cells and potential metabolic mechanism are important for better understanding of ITP. METHODS: The study enrolled 75 newly diagnosed ITP patients. The pathogens of patients were detected by metagenomic next-generation sequencing (mNGS). Plasma lipids were measured by liquid chromatography-mass spectrometry (LC-MS)...
September 1, 2022: Experimental Hematology & Oncology
https://read.qxmd.com/read/35906350/surgical-and-anaesthetic-outcomes-of-paediatric-splenectomies-at-a-tertiary-care-institution-in-south-india-a-retrospective-cohort
#32
JOURNAL ARTICLE
Aureen Ruby DCunha, Ekta Rai, Tarun John K Jacob, Anup J Devasia, Grace Rebekah
PURPOSE: Splenectomies though well-established in the successful management of several resistant haemoglobinopathies, have not been studied in detail in the paediatric population to assess the outcomes. We conducted this review to primarily assess the surgical and anaesthetic outcomes of paediatric splenectomies and secondarily highlight factors predictive for a high-risk splenectomy. METHODS: A 5 year retrospective chart review was made, and patient follow-up was done jointly using the hospital electronic medical records and telephonic calls...
July 29, 2022: Pediatric Surgery International
https://read.qxmd.com/read/35794926/severe-thrombocytopenic-purpura-associated-with-covid-19-in-a-pediatric-patient
#33
Adelina Raluca Marinescu, Voichita Elena Lazureanu, Virgil Filaret Musta, Narcisa Daniela Nicolescu, Alexandra Mocanu, Talida Georgiana Cut, Camelia Oana Muresan, Cristina Tudoran, Monica Licker, Ruxandra Laza
Purpose: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to cause a diverse spectrum of clinical manifestations ranging from mild, flu-like symptoms to severe progressive pneumonia, acute respiratory distress syndrome with or without other extrapulmonary impairment. Hematological changes such as lymphopenia, neutrophilia, and anemia as the disease progresses, are frequently found in COVID-19. Thrombocytopenia may be drug-induced or can occur secondary to sepsis, disseminated intravascular coagulation or bone marrow suppression...
2022: Infection and Drug Resistance
https://read.qxmd.com/read/35685646/plasma-metabolomics-identifies-the-dysregulated-metabolic-profile-of-primary-immune-thrombocytopenia-itp-based-on-gc-ms
#34
JOURNAL ARTICLE
Ziyan Zhang, Xiaojin Wu, Meng Zhou, Jiaqian Qi, Rui Zhang, Xueqian Li, Chang Wang, Changgeng Ruan, Yue Han
ITP is a common autoimmune bleeding disorder with elusive pathogenesis. Our study was implemented to profile the plasma metabolic alterations of patients diagnosed with ITP, aiming at exploring the potential novel biomarkers and partial mechanism of ITP. The metabolomic analysis of plasma samples was conducted using GC-MS on 98 ITP patients and 30 healthy controls (HCs). Age and gender matched samples were selected to enter the training set or test set respectively. OPLS-DA, t-test with FDR correction and ROC analyses were employed to screen out and evaluate the differential metabolites...
2022: Frontiers in Pharmacology
https://read.qxmd.com/read/35668857/clinical-implication-of-the-effect-of-the-production-of-neutralizing-antibodies-against-sars-cov-2-for-chronic-immune-thrombocytopenia-flare-up-associated-with-covid-19-infection-a-case-report-and-the-review-of-literature
#35
Chika Maekura, Ayako Muramatsu, Hiroaki Nagata, Haruya Okamoto, Akio Onishi, Daishi Kato, Reiko Isa, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Tsutomu Kobayashi, Keita Okumura, Tohru Inaba, Yoko Nukui, Junya Kuroda
Previous studies have demonstrated that the appropriate production of serum anti-severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) neutralizing antibody (nAb) plays a critical role in the recovery from coronavirus disease 2019 (COVID-19); however, the role of nAb production in the recovery from a flare-up of chronic immune thrombocytopenia (ITP) has been unknown. We here report the first retrospectively investigated case of serum anti-SARS-Cov-2 nAb production during chronic ITP flare-up triggered by COVID-19...
2022: Infection and Drug Resistance
https://read.qxmd.com/read/35524885/response-to-belimumab-in-thrombotic-thrombocytopenic-purpura-associated-with-systemic-lupus-erythematosus-a-case-based-review
#36
REVIEW
Shen-Ju Liang, Quan-You Zheng, Meng-Shan Li, Ming-Ye Lv, Wen-Ting Chen, Yi Yang
Thrombotic thrombocytopenic purpura (TTP), a life-threatening syndrome characterized by acute microangiopathic hemolytic anemia, thrombocytopenia, and visceral ischemia, can be classified as congenital TTP (inherited due to a mutation in ADAMTS13) and acquired TTP. The acquired TTP is further classified as idiopathic and secondary TTP. Systemic lupus erythematosus (SLE) is regarded as one of the most common causes of secondary TTP (SLE-TTP). In contrast to patients with idiopathic TTP, some patients with SLE-TTP, especially those diagnosed with refractory TTP, are resistant to plasma exchange and high-dose corticosteroids and usually require second-line drugs, including newly developed biologicals...
August 2022: Clinical Rheumatology
https://read.qxmd.com/read/35503254/high-affinity-autoreactive-plasma-cells-disseminate-through-multiple-organs-in-patients-with-immune-thrombocytopenic-purpura
#37
JOURNAL ARTICLE
Pablo Canales-Herrerias, Etienne Crickx, Matteo Broketa, Aurélien Sokal, Guilhem Chenon, Imane Azzaoui, Alexis Vandenberghe, Angga Perima, Bruno Iannascoli, Odile Richard-Le Goff, Carlos Castrillon, Guillaume Mottet, Delphine Sterlin, Ailsa Robbins, Marc Michel, Patrick England, Gael A Millot, Klaus Eyer, Jean Baudry, Matthieu Mahevas, Pierre Bruhns
The major therapeutic goal for immune thrombocytopenic purpura (ITP) is to restore normal platelet counts using drugs to promote platelet production or by interfering with mechanisms responsible for platelet destruction. Eighty percent of patients with ITP possess anti-integrin αIIbβ3 IgG autoantibodies that cause platelet opsonization and phagocytosis. The spleen is considered the primary site of autoantibody production by autoreactive B cells and platelet destruction. The immediate failure in approximately 50% of patients to recover a normal platelet count after anti-CD20 rituximab-mediated B cell depletion and splenectomy suggests that autoreactive, rituximab-resistant, IgG-secreting B cells (IgG-SCs) reside in other anatomical compartments...
June 15, 2022: Journal of Clinical Investigation
https://read.qxmd.com/read/35414712/glucocorticoid-receptor-modulates-myeloid-derived-suppressor-cell-function-via-mitochondrial-metabolism-in-immune-thrombocytopenia
#38
JOURNAL ARTICLE
Yu Hou, Jie Xie, Shuwen Wang, Daqi Li, Lingjun Wang, Haoyi Wang, Xiaofei Ni, Shaoqiu Leng, Guosheng Li, Ming Hou, Jun Peng
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of immature cells and natural inhibitors of adaptive immunity. Intracellular metabolic changes in MDSCs exert a direct immunological influence on their suppressive activity. Our previous study demonstrated that high-dose dexamethasone (HD-DXM) corrected the functional impairment of MDSCs in immune thrombocytopenia (ITP); however, the MDSC population was not restored in nonresponders, and the mechanism remained unclear. In this study, altered mitochondrial physiology and reduced mitochondrial gene transcription were detected in MDSCs from HD-DXM nonresponders, accompanied by decreased levels of carnitine palmitoyltransferase-1 (CPT-1), a rate-limiting enzyme in fatty acid oxidation (FAO)...
April 12, 2022: Cellular & Molecular Immunology
https://read.qxmd.com/read/35132908/refractory-immune-thrombocytopenia-successfully-treated-with-bortezomib-in-a-child-with-22q11-2-deletion-syndrome-complicated-by-evans-syndrome-and-hypogammaglobulinemia
#39
JOURNAL ARTICLE
Francesca Conti, Francesca Gottardi, Mattia Moratti, Tamara Belotti, Simona Ferrari, Paola Selva, Mirna Bassi, Daniele Zama, Andrea Pession
Treatment of refractory autoimmune cytopenias (AICs) and Evans syndrome (ES) represent a great challenge in pediatric setting, where an underlying primary immunodeficiency is recurrent. Frequently, second or third line treatments are employed, with an increased risk of toxicity and infections. The advent of novel drugs is the object of research in order to modify the management of these patients.We report a case of successful use of bortezomib in a child with 22q11.2 deletion syndrome and CVID-like phenotype with a multi-refractory severe ES...
July 4, 2022: Platelets
https://read.qxmd.com/read/35116723/potential-effect-of-epigenetic-drugs-in-the-treatment-of-multiple-site-extramedullary-plasmacytoma-involving-the-respiratory-system-a-case-report-and-review-of-the-literature
#40
Longcan Cheng, Lixun Guan, Yuanyuan Xu, You Liu, Wenshuai Zheng, Ting Yang, Min Tan, Dongkai Zhu, Xiaoning Gao, Quanshun Wang
We report the case of a 23-year-old man with a medical history of idiopathic thrombocytopenic purpura (ITP) and newly diagnosed with the Epstein-Barr virus (EBV)-positive multiple-site extramedullary plasmacytoma (EMP), which involves the respiratory system. The patient was referred to our hospital because of progressive nasal congestion and nasal mass. Nasopharyngoscopy and bronchoscopy were performed. The biopsy pathological hematoxylin and eosin (HE) staining indicated plasma cell myeloma, and further immunohistochemistry CD99(+), CD79a(+), CD38(+), MUM-1(+), and Lambda(+) confirmed the diagnosis...
September 2021: Translational Cancer Research
keyword
keyword
117360
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.